US Patent Issued to City University of Hong Kong on Oct. 20 for "Method of treating breast cancer in a subject by inhibiting TUBB2B" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,163, issued on Oct. 20, was assigned to City University of Hong Kong (Kowloon, Hong Kong).

"Method of treating breast cancer in a subject by inhibiting TUBB2B" was invented by Yuet Ming Rebecca Chin (Kowloon, Hong Kong), Jianyang Hu (Kowloon, Hong Kong) and Qingling He (Kowloon, Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a designed short hairpin RNA (shRNA) containing RNA interference (RNAi) molecules. RNAi molecules hybridizes to a certain sequence of mRNA of TUBB2B. This invention develops a method of inhibiting TUBB2B expression in mammalian cell and a method of treating or controlling a cancer or tumor media...